abstract |
The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I n n n n n n n n n n wherein a, b, R 1 , R 2 , R 3 , and R 4 are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. |